Category - News

Markets

Roth starts BioSig Technologies at buy; PT $14

Roth Capital Partners initiated coverage of BioSig Technologies (NASDAQ:BSGM) with a “buy” rating and $14 price target. The stock closed at $3.97 on Dec. 4. BioSig is a medical device company developing the PURE EP...

December 6, 2018

Markets

Roth starts CorMedix at buy; PT $6

Roth Capital Partners launched coverage of CorMedix (NASDAQ:CRMD) with a “buy” rating and price target of $6. The stock closed at $1.35 on Dec. 4. CorMedix is developing Neutrolin for the prevention of catheter-related...

December 6, 2018

Executive Moves

Novavax promotes Jill Hoyt and Biegie Lee

Novavax (NASDAQ:NVAX) promoted Jill Hoyt to SVP of human resources and Biegie Lee to VP of information technology.

December 5, 2018

Developments

Scientus Pharma receives U.S. patent for cannabis extraction technology

Closely-held Scientus Pharma, through its HydRx Farms unit, received a U.S. patent that provides intellectual property protection for its decarboxylation method for extraction and activation of active pharmaceutical...

December 5, 2018

Developments

BeyondSpring presents positive Plinabulin CIN data at ASH

BeyondSpring (NASDAQ:BYSI) reported new data from its lead asset, Plinabulin, for the prevention of chemotherapy-induced neutropenia (CIN) at the American Society of Hematology (ASH) annual meeting. Plinabulin is...

December 4, 2018

Markets

BTIG starts Valeritas Holdings at buy; PT $1

BTIG initiated coverage of Valeritas Holdings (NASDAQ:VLRX) with a “buy” rating and price target of $1. The stock closed at 39 cents on Dec. 3. Valeritas sells V-Go, the only pump on the market for Type 2 diabetes...

December 4, 2018

Executive Moves

Kelley Dealhoy joins Interface Biologics as VP of business development

Closely-held Interface Biologics (IBI) appointed Kelley Dealhoy to the position of VP business development.

December 4, 2018

Developments

Canopy Growth in equity investment, supply deal, strategic partnership with 48North

Canopy Growth (TSX:WEED; NYSE: CGC) inked an investment financing, and partnership and a supply agreement with 48North Cannabis (TSXV:NRTH). Under the supply accord, 48North would supply Canopy with dried cannabis...

December 3, 2018

Developments

Canopy Growth to purchase cannabis extract from MediPharm Labs

Canopy Growth (TSX:WEED; NYSE:CGC) has entered an 18-month strategic supply agreement with a unit of MediPharm Labs (TSXV:LABS) to purchase up to 900 kg of cannabis extract. Canopy Growth has committed to purchase a...

November 29, 2018

Markets

Maxim starts Agile Therapeutics at buy; PT $3

Maxim Group initiated coverage of Agile Therapeutics (NASDAQ:AGRX) with a “buy” rating and $3 price target. The stock closed at 81 cents on Nov. 28.

November 29, 2018

Category - News

Subscribe